Adaptimmune Therapeutics Plc ADR (ADAPY)

$0.05 0.00 (-1.82%)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 45,989,301
Avg Vol 115,232,406
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 15%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Adaptimmune Therapeutics plc, a commercial-stage biopharmaceutical company, provides novel cell therapies primarily to cancer patients in the United States and the United Kingdom. It develops TECELRA (famitresgene autoleucel or afami-cel), a genetically modified autologous T-cell immunotherapy for the treatment of adults with unresectable or metastatic synovial sarcoma; Lete-cel for the treatment of synovial sarcoma and myxoid liposarcoma; and ADP-5701, which is in Phase 1 clinical trial for the...

Industry: Biotechnology
Sector: Healthcare
Phone: 44 12 3543 0000
Address:
60 Jubilee Avenue, Milton Park, Abingdon, United Kingdom
PaidPiper
PaidPiper May. 15 at 11:01 PM
$ADAPY meaning ppl who aren't willing to sell for 2 cents, likely aren't waiting for 3 cents either. They're waiting at 10 or higher. So keeping a lid on it at 2 is to protect it from jumping much higher too soon.
0 · Reply
SillyGooze
SillyGooze May. 15 at 6:29 PM
$ADAPY looks like the jiggle machine finally broke.
1 · Reply
Fab83
Fab83 May. 15 at 5:22 PM
$ADAPY You mean the Gap to $29 😉
0 · Reply
PaidPiper
PaidPiper May. 15 at 5:10 PM
$ADAPY this stalls out everyday bc the next available liquidity pool is too far above 2 cents. Eventually it'll break 2 cents and gap to 10. 95% sure
0 · Reply
TornadoChasers
TornadoChasers May. 15 at 4:47 PM
$AGMH $ADAPY TT
0 · Reply
duepillagence
duepillagence May. 15 at 3:07 PM
$ADAPY Great news on takeover code! Question, but aren't we guaranteed a set share price of $.65 or am I mistaken?
2 · Reply
michele3
michele3 May. 15 at 2:44 PM
$ADAPY I see a big green day!!!
0 · Reply
berat2209
berat2209 May. 15 at 2:41 PM
$ADAPY When will the development we’re expecting take place?
0 · Reply
US_Bull
US_Bull May. 15 at 11:12 AM
$ADAPY This is what S-3 form is there are tons of sections about merger and acquisition read especially the section at pg. 15 about the "Takeover Code." It says if there are no changes to where they operate from but there now indeed changes due to USW. So SH's are indeed included in the provisions of the takeover code. Also the 400 million prospectus and warrants. https://www.adaptimmune.com/investors-and-media/sec-filings/all-sec-filings/content/0001104659-25-036359/0001104659-25-036359.pdf
0 · Reply
US_Bull
US_Bull May. 15 at 11:05 AM
$ADAPY Their last communication from the radiosilence was the "immediate" withdrawal of S-form, which is a prospectus. This goes perfectly hand in hand with a corporate action taking place behind the curtains. Cause you have no reason to issue shares if you are getting sold anyways. On top of it you cc a partner on the SEC document specializing in corporate actions and M&A.
0 · Reply
Latest News on ADAPY
No data available.
PaidPiper
PaidPiper May. 15 at 11:01 PM
$ADAPY meaning ppl who aren't willing to sell for 2 cents, likely aren't waiting for 3 cents either. They're waiting at 10 or higher. So keeping a lid on it at 2 is to protect it from jumping much higher too soon.
0 · Reply
SillyGooze
SillyGooze May. 15 at 6:29 PM
$ADAPY looks like the jiggle machine finally broke.
1 · Reply
Fab83
Fab83 May. 15 at 5:22 PM
$ADAPY You mean the Gap to $29 😉
0 · Reply
PaidPiper
PaidPiper May. 15 at 5:10 PM
$ADAPY this stalls out everyday bc the next available liquidity pool is too far above 2 cents. Eventually it'll break 2 cents and gap to 10. 95% sure
0 · Reply
TornadoChasers
TornadoChasers May. 15 at 4:47 PM
$AGMH $ADAPY TT
0 · Reply
duepillagence
duepillagence May. 15 at 3:07 PM
$ADAPY Great news on takeover code! Question, but aren't we guaranteed a set share price of $.65 or am I mistaken?
2 · Reply
michele3
michele3 May. 15 at 2:44 PM
$ADAPY I see a big green day!!!
0 · Reply
berat2209
berat2209 May. 15 at 2:41 PM
$ADAPY When will the development we’re expecting take place?
0 · Reply
US_Bull
US_Bull May. 15 at 11:12 AM
$ADAPY This is what S-3 form is there are tons of sections about merger and acquisition read especially the section at pg. 15 about the "Takeover Code." It says if there are no changes to where they operate from but there now indeed changes due to USW. So SH's are indeed included in the provisions of the takeover code. Also the 400 million prospectus and warrants. https://www.adaptimmune.com/investors-and-media/sec-filings/all-sec-filings/content/0001104659-25-036359/0001104659-25-036359.pdf
0 · Reply
US_Bull
US_Bull May. 15 at 11:05 AM
$ADAPY Their last communication from the radiosilence was the "immediate" withdrawal of S-form, which is a prospectus. This goes perfectly hand in hand with a corporate action taking place behind the curtains. Cause you have no reason to issue shares if you are getting sold anyways. On top of it you cc a partner on the SEC document specializing in corporate actions and M&A.
0 · Reply
US_Bull
US_Bull May. 15 at 10:54 AM
$ADAPY Give me ~ 0.50$ and let us call it a day I think that is where we are at ~ 125-150 million today.
0 · Reply
US_Bull
US_Bull May. 15 at 10:50 AM
$ADAPY If a sale is indeed happening behind the doors I would assume it would need time to close before the service agreement ends in June unless of course the suitor is USW.
0 · Reply
US_Bull
US_Bull May. 15 at 10:48 AM
$ADAPY We are close any day now and end of June.
1 · Reply
US_Bull
US_Bull May. 15 at 10:45 AM
$ADAPY For weeks they have been keeping the SP ~ similar in the German exchanges and in the US. Let us get the final corporate PR already.
1 · Reply
US_Bull
US_Bull May. 15 at 10:42 AM
$ADAPY Appears to me they have finished up odds and ends with respect to lete-cel BLA (likely submitted already in regulatory review backend of the process) and PRAME and CD70 IND. We just need the final PR stating who the torch is taken over by.
0 · Reply
Dipshit101
Dipshit101 May. 15 at 3:53 AM
$ADAPY wish I could sign up as a expert, But I don’t know what it requires. I have money to blow, and wish I had blow to blow but no no no I don’t blow no mo, I was tired of waking up on the floor…. Them fkers kicking ass with the dumps I assume
1 · Reply
US_Bull
US_Bull May. 14 at 10:55 PM
$ADAPY
0 · Reply
US_Bull
US_Bull May. 14 at 10:54 PM
$ADAPY
0 · Reply
US_Bull
US_Bull May. 14 at 10:53 PM
$ADAPY
0 · Reply
US_Bull
US_Bull May. 14 at 10:52 PM
$ADAPY
0 · Reply
US_Bull
US_Bull May. 14 at 10:49 PM
$ADAPY Another one of the last standings bites the dust. "...Accountable for content and drafting of multiple drug substance/drug product module 3 supportive and compliance sections, and the associated linked consistency with other relevant sections, of the BLA for Lete-cel and IND of next TCR T-cell pipeline asset..." Two things from the above another indication that the BLA for lete-cel may very well have been submitted already and may be in deep regulatory review. Look at my previous posts where another poster said they had passed regulatory inspection on the facilities (which usually takes place after acceptance of a BLA). Second notice the IND part. So if the main person for the IND is gone who is going to take the drug through clinics hmmmm pretty obvious there is a suitor ready to take over.
0 · Reply
US_Bull
US_Bull May. 14 at 7:40 PM
$ADAPY Not sure where you are getting that date from. Remember last Q they didn't release earnings part of the reason why they are on the expert market and delisted themselves. I am not counting to see any earnings. Next PR will very likely be a decision about the future of the company whether they form a partnership with cash infusion or get sold.
0 · Reply